Todd C. Davis

Insider Reports History

Entity
Individual
Location
11119 North Torrey Pines Road, Suite 200, La Jolla, CA
Signature
Kathleen A. McGowan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Todd C. Davis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LIGAND PHARMACEUTICALS INC Chief Executive Officer, Director Common Stock 123K $12M $97.39 Aug 8, 2024 Direct
PIERIS PHARMACEUTICALS, INC. Director Common Stock 113K $1.79M $15.88 Dec 13, 2024 Direct
Vaxart, Inc. Director Common Stock 126K $301K $2.39 Aug 4, 2022 Direct
Chromocell Therapeutics Corp Director Restricted Stock Units 263K $255K $0.97 Nov 13, 2024 Direct
Chromocell Therapeutics Corp Director Common Stock 29.2K $27.4K $0.94 Feb 21, 2024 Direct
Vaxart, Inc. Director Stock Option (right to buy) 44.2K Aug 4, 2022 Direct
PIERIS PHARMACEUTICALS, INC. Director Stock Option (right to buy) 24.7K Dec 13, 2024 Direct
BIODELIVERY SCIENCES INTERNATIONAL INC Director Common Stock 0 $1.80 Mar 22, 2022 Direct
BIODELIVERY SCIENCES INTERNATIONAL INC Director Restricted Stock Units 0 Mar 22, 2022 Direct
BIODELIVERY SCIENCES INTERNATIONAL INC Director Stock Options (right to buy) 0 $2.93 Mar 22, 2022 Direct
Chromocell Therapeutics Corp Director Secured Convertible Promissory Note 0 Feb 21, 2024 Direct
LIGAND PHARMACEUTICALS INC Chief Executive Officer, Director Non-Qualified Stock Option (right to buy) 0 Mar 25, 2024 Direct

Insider Reports Filed by Todd C. Davis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PVLA PALVELLA THERAPEUTICS, INC. Dec 13, 2024 1 $0 4 Dec 17, 2024 Director
PVLA PALVELLA THERAPEUTICS, INC. Dec 13, 2024 0 $0 3 Dec 16, 2024 Director
CHRO Chromocell Therapeutics Corp Nov 13, 2024 1 $0 4 Nov 15, 2024 Director
LGND LIGAND PHARMACEUTICALS INC Aug 8, 2024 1 $243K 4 Aug 9, 2024 Chief Executive Officer, Director
LGND LIGAND PHARMACEUTICALS INC Jun 28, 2024 1 $21.2K 4 Jul 2, 2024 Chief Executive Officer, Director
CHRO Chromocell Therapeutics Corp Jun 14, 2024 1 $0 4 Jun 18, 2024 Director
LGND LIGAND PHARMACEUTICALS INC Mar 25, 2024 8 $919K 4 Mar 27, 2024 Chief Executive Officer, Director
LGND LIGAND PHARMACEUTICALS INC Feb 27, 2024 2 $0 4 Feb 29, 2024 CHIEF EXECUTIVE OFFICER, Director
CHRO Chromocell Therapeutics Corp Feb 21, 2024 2 -$35K 4 Feb 23, 2024 Director
LGND LIGAND PHARMACEUTICALS INC Feb 15, 2024 1 -$103K 4 Feb 16, 2024 CHIEF EXECUTIVE OFFICER, Director
CHRO Chromocell Therapeutics Corp Feb 15, 2024 0 $0 3 Feb 15, 2024 Director
LGND LIGAND PHARMACEUTICALS INC Sep 22, 2023 1 $238K 4 Sep 25, 2023 CHIEF EXECUTIVE OFFICER, Director
LGND LIGAND PHARMACEUTICALS INC Jun 9, 2023 1 -$31K 4 Jun 13, 2023 CHIEF EXECUTIVE OFFICER, Director
LGND LIGAND PHARMACEUTICALS INC Feb 23, 2023 2 $0 4 Feb 27, 2023 Chief Executive Officer, Director
LGND LIGAND PHARMACEUTICALS INC Dec 22, 2022 1 $0 4 Dec 27, 2022 Chief Executive Officer, Director
LGND LIGAND PHARMACEUTICALS INC Dec 5, 2022 1 $0 4 Dec 6, 2022 Chief Executive Officer, Director
VXRT Vaxart, Inc. Aug 4, 2022 2 $0 4 Aug 8, 2022 Director
LGND LIGAND PHARMACEUTICALS INC Jun 10, 2022 2 $0 4 Jun 13, 2022 Director
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC Mar 22, 2022 4 $0 4 Mar 22, 2022 Director
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC Jan 27, 2022 4 $314K 4 Feb 1, 2022 Director
VXRT Vaxart, Inc. Dec 22, 2021 1 $0 4 Dec 23, 2021 Director
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC Aug 6, 2021 2 $0 4 Aug 10, 2021 Director
VXRT Vaxart, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2021 Director
LGND LIGAND PHARMACEUTICALS INC Jun 4, 2021 2 $0 4 Jun 7, 2021 Director
VXRT Vaxart, Inc. Nov 18, 2019 1 $0 4/A Jun 14, 2021 Director